| Budesonide Teva Pharma 0.5 mg/2 ml Nebuliser Suspension PA0749/207/002 |
Budesonide |
Teva Pharma B.V. |
Marketed |
| Budesonide Teva Pharma 1 mg/2 ml Nebuliser Suspension PA0749/207/003 |
Budesonide |
Teva Pharma B.V. |
Marketed |
| Bufomix Easyhaler 160 micrograms/4.5 micrograms/inhalation, inhalation powder PA1327/015/002 |
Budesonide, Formoterol fumarate dihydrate |
Orion Corporation |
Marketed |
| Bufomix Easyhaler 320 micrograms/9 micrograms/inhalation, inhalation powder PA1327/015/003 |
Budesonide, Formoterol fumarate dihydrate |
Orion Corporation |
Marketed |
| Bufomix Easyhaler 80 micrograms/4.5 micrograms/inhalation, inhalation powder PA1327/015/004 |
Budesonide, Formoterol fumarate dihydrate |
Orion Corporation |
Marketed |
| Bulexin 2 mg/0.5 mg sublingual tablets PA0281/267/001 |
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate |
Pinewood Laboratories Limited |
Marketed |
| Bulexin 4 mg/1 mg sublingual tablets PA0281/267/002 |
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate |
Pinewood Laboratories Limited |
Not marketed |
| Bulexin 8 mg/2 mg sublingual tablets PA0281/267/003 |
Buprenorphine hydrochloride, Naloxone hydrochloride dihydrate |
Pinewood Laboratories Limited |
Marketed |
| Bupivacaine 2.5 mg/ml Solution for Injection PA2299/035/001 |
Bupivacaine hydrochloride, monohydrate |
Baxter Holding B.V. |
Not marketed |
| Bupivacaine 2.5 mg/ml Solution for injection PA1122/029/001 |
Bupivacaine hydrochloride, anhydrous |
Noridem Enterprises Limited |
Not marketed |
| Bupivacaine 5 mg/ml Solution for injection PA1122/029/002 |
Bupivacaine hydrochloride, anhydrous |
Noridem Enterprises Limited |
Not marketed |
| Bupivacaine 5 mg/ml Solution for Injection PA2299/035/002 |
Bupivacaine hydrochloride, monohydrate |
Baxter Holding B.V. |
Marketed |
| Bupivacaine Heavy 5 mg/ml solution for injection PA1968/025/001 |
Bupivacaine hydrochloride monohydrate |
Laboratoire Aguettant |
Marketed |
| Bupivacaine Hydrochloride 0.25% w/v Solution for Injection PA0073/091/001 |
Bupivacaine hydrochloride |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Bupivacaine Hydrochloride 0.5% w/v Solution for Injection PA0073/091/002 |
Bupivacaine hydrochloride |
Mercury Pharmaceuticals (Ireland) Ltd |
Marketed |
| Buplex 200mg film-coated tablets PA1986/116/001 |
Ibuprofen |
Teva B.V. |
Marketed |
| Buplex 400mg film-coated tablets PA1986/116/002 |
Ibuprofen |
Teva B.V. |
Marketed |
| Buplex Rx 200 mg film-coated tablets PA1986/117/001 |
Ibuprofen |
Teva B.V. |
Marketed |
| Buplex Rx 400 mg film-coated tablets PA1986/117/002 |
Ibuprofen |
Teva B.V. |
Not marketed |
| Buplex Rx 600 mg film-coated tablets PA1986/117/003 |
Ibuprofen |
Teva B.V. |
Not marketed |
| Buprenorphine 0.4 mg Sublingual Tablets PA1567/001/001 |
Buprenorphine hydrochloride |
Activase Pharmaceuticals Limited |
Not marketed |
| Buprenorphine 2 mg Sublingual Tablets PA23142/003/001 |
Buprenorphine hydrochloride |
Aspire Pharma (Malta) Limited |
Not marketed |
| Buprenorphine 2 mg Sublingual Tablets PA1567/001/002 |
Buprenorphine hydrochloride |
Activase Pharmaceuticals Limited |
Not marketed |
| Buprenorphine 8 mg Sublingual Tablets PA23142/003/002 |
Buprenorphine hydrochloride |
Aspire Pharma (Malta) Limited |
Not marketed |
| Buprenorphine 8 mg Sublingual Tablets PA1567/001/003 |
Buprenorphine hydrochloride |
Activase Pharmaceuticals Limited |
Not marketed |
| Buprenorphine Neuraxpharm EU/1/24/1809/001-003 |
Buprenorphine hydrochloride |
Laboratorios Lesvi, S.L. |
— |
| Buprenorphine Neuraxpharm EU/1/24/1809/004-006 |
Buprenorphine hydrochloride |
Laboratorios Lesvi, S.L. |
— |
| Buprenorphine Neuraxpharm EU/1/24/1809/007-009 |
Buprenorphine hydrochloride |
Laboratorios Lesvi, S.L. |
— |
| Buprenorphine Neuraxpharm EU/1/24/1809/010-012 |
Buprenorphine hydrochloride |
Laboratorios Lesvi, S.L. |
— |
| Burinex 1 mg Tablets PA22650/001/001 |
Bumetanide |
Karo Pharma AB |
Marketed |
| Burinex 5 mg Tablets PA22650/001/002 |
Bumetanide |
Karo Pharma AB |
Not marketed |
| Buscopan 10 mg Coated Tablets PA23180/016/002 |
Hyoscine butylbromide |
Opella Healthcare France SAS T/A Sanofi |
Marketed |
| Buscopan Ampoules 20 mg/ml Solution for Injection PA23180/016/001 |
Hyoscine butylbromide |
Opella Healthcare France SAS T/A Sanofi |
Marketed |
| Buscopan Rx 10mg Coated Tablets PA23180/022/001 |
Hyoscine butylbromide |
Opella Healthcare France SAS T/A Sanofi |
Not marketed |
| Busulfan Fresenius Kabi 6 mg/ml concentrate for solution for infusion EU/1/14/951/001 |
Busulfan |
Fresenius Kabi Deutschland GmbH |
— |
| BuTrans 10 micrograms/hour transdermal patch PA1688/002/002 |
Buprenorphine |
Mundipharma Pharmaceuticals Limited |
Marketed |
| BuTrans 15 microgram/hour transdermal patch PA1688/002/004 |
Buprenorphine |
Mundipharma Pharmaceuticals Limited |
Marketed |
| BuTrans 20 micrograms/hour transdermal patch PA1688/002/003 |
Buprenorphine |
Mundipharma Pharmaceuticals Limited |
Marketed |
| BuTrans 5 micrograms/hour transdermal patch PA1688/002/001 |
Buprenorphine |
Mundipharma Pharmaceuticals Limited |
Marketed |
| Buttercup Bronchostop Berry Flavour Cough Pastilles TR2006/001/002 |
|
Kwizda Pharma GmbH |
— |
| Buttercup Bronchostop Cough Syrup TR2006/001/001 |
|
Kwizda Pharma GmbH |
— |
| Buttercup Bronchostop Day & Night Oral Solution TR2006/002/001 |
|
Kwizda Pharma GmbH |
Not marketed |
| Buvidal 128 mg Prolonged-release solution for injection EU/1/18/1336/007 |
Buprenorphine |
Camurus AB |
— |
| Buvidal 16 mg Prolonged-release solution for injection EU/1/18/1336/002 |
Buprenorphine |
Camurus AB |
— |
| Buvidal 160 mg Prolonged-release solution for injection EU/1/18/1336/009 |
Buprenorphine |
Camurus AB |
— |
| Buvidal 24 mg Prolonged-release solution for injection EU/1/18/1336/003 |
Buprenorphine |
Camurus AB |
— |
| Buvidal 32 mg Prolonged-release solution for injection EU/1/18/1336/004 |
Buprenorphine |
Camurus AB |
— |
| Buvidal 64 mg Prolonged-release solution for injection EU/1/18/1336/005 |
Buprenorphine |
Camurus AB |
— |
| Buvidal 8 mg Prolonged-release solution for injection EU/1/18/1336/001 |
Buprenorphine |
Camurus AB |
— |
| Buvidal 96 mg Prolonged-release solution for injection EU/1/18/1336/006 |
Buprenorphine |
Camurus AB |
— |